ANTIPLAQUE INGREDIENT REVIEW BY FDA'S PLAQUE SUBCOMMITTEE
This article was originally published in The Tan Sheet
Executive Summary
ANTIPLAQUE INGREDIENT REVIEW BY FDA'S PLAQUE SUBCOMMITTEE will initially include 12 single ingredients and four combinations, OTC Plaque Products Subcommittee Acting Chair Robert Genco, DDS/PhD, State University of New York School of Medicine, reported at a June 28-29 meeting. The subcommittee is charged with reviewing the safety and efficacy and risk/benefit of antiplaque ingredients ("The Tan Sheet" Aug. 9, 1993, p. 1). Genco said the committee plans to review single ingredients when used in combination products at a later date.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning